Evidence map›Paper›PMID 42213249›Full record

ReviewWorld journal of microbiology & biotechnology2026

Rethinking microbial biopesticide development and uptake.

Travis R Glare, Andy Sheppard, Mark R H Hurst, Louise Thatcher, Marta Gallart, Sarina Macfadyen, Simon Law, Maureen O'Callaghan

Abstract readReview
In one paragraph

Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Travis R GlareLincoln Agritech Ltd, Lincoln University, Canterbury, New Zealand. travis.glare@lincoln.ac.nz.ORCID http://orcid.org/0000-0001-7795-8709
Andy SheppardHealth and Biosecurity, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clunies Ross Street, Acton, ACT, Australia.ORCID http://orcid.org/0000-0002-6188-7122
Mark R H HurstBioeconomy Science Institute, Tuhiraki, 19 Ellesmere Junction Road, Lincoln, Canterbury, 7608, New Zealand.ORCID http://orcid.org/0000-0001-5826-5253
Louise ThatcherAgriculture and Food, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clunies Ross Street, Acton, ACT, Australia.ORCID http://orcid.org/0000-0001-7622-6610
Marta GallartAgriculture and Food, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clunies Ross Street, Acton, ACT, Australia.ORCID http://orcid.org/0000-0001-5096-6354
Sarina MacfadyenAgriculture and Food, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clunies Ross Street, Acton, ACT, Australia.ORCID http://orcid.org/0000-0003-3553-4910
Simon LawAgriculture and Food, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Clunies Ross Street, Acton, ACT, Australia.ORCID http://orcid.org/0000-0003-0389-6650
Maureen O'CallaghanBioeconomy Science Institute, Tuhiraki, 19 Ellesmere Junction Road, Lincoln, Canterbury, 7608, New Zealand.ORCID http://orcid.org/0000-0001-7406-3854

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biopesticides, pesticides based on living organisms and/or their bioactive compounds, are increasingly being used as alternatives and replacements to chemical and synthetic pesticides. This is largely due to human and environmental safety concerns, the emergence of pest resistance (collectively insect pests, weeds and diseases), and the move towards holistic pest and disease control approaches. While the number and diversity of agents used in biopesticides slowly increases, the approach to developing these products remains largely ad hoc, resulting in less than 10% success rate for development projects. Here we review the major characteristics of successful biopesticides. Our treatise focuses on the benefits of considering the entire development pathway and requirements of the intended product application before embarking on the costly process of biopesticide development and commercialisation. By a priori consideration of the characteristics of both the target pest and market, and the potential limitations of the candidate microorganism and/or its bioactives (e.g. environmental persistence, ease and cost of mass production), the development pipeline can be streamlined and targeted on projects with the greatest likelihood of success. We provide a detailed consideration of the key factors that underpin successful (or not) biopesticide development and provide decision trees to support the a priori process.

Indexed as

Biological Control AgentsPest Control, BiologicalAnimalsBacteriaHumansInsectaPesticidesBiological Control AgentsPesticidesBiocontrol agentsCommercialisationDecision-support frameworkEntomopathogensMarket driven developmentMicrobial biopesticidesMode of actionProduct development pipelineRegulatory pathwaysSustainable pest managementUptake and adoption barriers

Identifiers

PMID42213249
PMCPMC13221321

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.